nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—Nasopharyngitis—Doxorubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000876	0.000876	CcSEcCtD
Gadofosveset trisodium—Vomiting—Bleomycin—testicular cancer	0.000876	0.000876	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Methotrexate—testicular cancer	0.000873	0.000873	CcSEcCtD
Gadofosveset trisodium—Infestation—Methotrexate—testicular cancer	0.000873	0.000873	CcSEcCtD
Gadofosveset trisodium—Hypotension—Etoposide—testicular cancer	0.000869	0.000869	CcSEcCtD
Gadofosveset trisodium—Rash—Bleomycin—testicular cancer	0.000869	0.000869	CcSEcCtD
Gadofosveset trisodium—Pain—Cisplatin—testicular cancer	0.000868	0.000868	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Bleomycin—testicular cancer	0.000868	0.000868	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Ifosfamide—testicular cancer	0.000867	0.000867	CcSEcCtD
Gadofosveset trisodium—Renal failure—Methotrexate—testicular cancer	0.000858	0.000858	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Doxorubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Doxorubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Epirubicin—testicular cancer	0.000847	0.000847	CcSEcCtD
Gadofosveset trisodium—Asthenia—Ifosfamide—testicular cancer	0.000845	0.000845	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Cisplatin—testicular cancer	0.000836	0.000836	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Etoposide—testicular cancer	0.000835	0.000835	CcSEcCtD
Gadofosveset trisodium—Pruritus—Ifosfamide—testicular cancer	0.000833	0.000833	CcSEcCtD
Gadofosveset trisodium—Haematuria—Methotrexate—testicular cancer	0.000833	0.000833	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Etoposide—testicular cancer	0.000829	0.000829	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Epirubicin—testicular cancer	0.000827	0.000827	CcSEcCtD
Gadofosveset trisodium—Nausea—Bleomycin—testicular cancer	0.000818	0.000818	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Epirubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Gadofosveset trisodium—Infestation—Epirubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Gadofosveset trisodium—Vomiting—Dactinomycin—testicular cancer	0.000817	0.000817	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Doxorubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Gadofosveset trisodium—Rash—Dactinomycin—testicular cancer	0.00081	0.00081	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Etoposide—testicular cancer	0.000808	0.000808	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Ifosfamide—testicular cancer	0.000806	0.000806	CcSEcCtD
Gadofosveset trisodium—Renal failure—Epirubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Etoposide—testicular cancer	0.000803	0.000803	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Cisplatin—testicular cancer	0.000802	0.000802	CcSEcCtD
Gadofosveset trisodium—Fatigue—Etoposide—testicular cancer	0.000802	0.000802	CcSEcCtD
Gadofosveset trisodium—Pain—Etoposide—testicular cancer	0.000795	0.000795	CcSEcCtD
Gadofosveset trisodium—Constipation—Etoposide—testicular cancer	0.000795	0.000795	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Epirubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Gadofosveset trisodium—Haematuria—Epirubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Gadofosveset trisodium—Dizziness—Ifosfamide—testicular cancer	0.000779	0.000779	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Methotrexate—testicular cancer	0.000774	0.000774	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Methotrexate—testicular cancer	0.000769	0.000769	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Etoposide—testicular cancer	0.000766	0.000766	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Doxorubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Gadofosveset trisodium—Nausea—Dactinomycin—testicular cancer	0.000763	0.000763	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Etoposide—testicular cancer	0.00076	0.00076	CcSEcCtD
Gadofosveset trisodium—Infestation—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Methotrexate—testicular cancer	0.000756	0.000756	CcSEcCtD
Gadofosveset trisodium—Vomiting—Ifosfamide—testicular cancer	0.000749	0.000749	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Cisplatin—testicular cancer	0.000748	0.000748	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Gadofosveset trisodium—Renal failure—Doxorubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Gadofosveset trisodium—Rash—Ifosfamide—testicular cancer	0.000742	0.000742	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Ifosfamide—testicular cancer	0.000742	0.000742	CcSEcCtD
Gadofosveset trisodium—Urticaria—Etoposide—testicular cancer	0.000739	0.000739	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Etoposide—testicular cancer	0.000735	0.000735	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Etoposide—testicular cancer	0.000735	0.000735	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Doxorubicin—testicular cancer	0.000735	0.000735	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Methotrexate—testicular cancer	0.000733	0.000733	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Epirubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Gadofosveset trisodium—Asthenia—Cisplatin—testicular cancer	0.000728	0.000728	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Methotrexate—testicular cancer	0.000728	0.000728	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Epirubicin—testicular cancer	0.000725	0.000725	CcSEcCtD
Gadofosveset trisodium—Haematuria—Doxorubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Epirubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Epirubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Methotrexate—testicular cancer	0.000708	0.000708	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Epirubicin—testicular cancer	0.000707	0.000707	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Gadofosveset trisodium—Chills—Methotrexate—testicular cancer	0.000703	0.000703	CcSEcCtD
Gadofosveset trisodium—Nausea—Ifosfamide—testicular cancer	0.000699	0.000699	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Cisplatin—testicular cancer	0.000694	0.000694	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Doxorubicin—testicular cancer	0.000691	0.000691	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Methotrexate—testicular cancer	0.000687	0.000687	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Epirubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Etoposide—testicular cancer	0.000685	0.000685	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Methotrexate—testicular cancer	0.000682	0.000682	CcSEcCtD
Gadofosveset trisodium—Erythema—Methotrexate—testicular cancer	0.000682	0.000682	CcSEcCtD
Gadofosveset trisodium—Flushing—Epirubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Epirubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Doxorubicin—testicular cancer	0.000675	0.000675	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Doxorubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Gadofosveset trisodium—Asthenia—Etoposide—testicular cancer	0.000667	0.000667	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Doxorubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Epirubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Gadofosveset trisodium—Chills—Epirubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Gadofosveset trisodium—Pruritus—Etoposide—testicular cancer	0.000658	0.000658	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Epirubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Doxorubicin—testicular cancer	0.000654	0.000654	CcSEcCtD
Gadofosveset trisodium—Vomiting—Cisplatin—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—testicular cancer	0.000643	0.000643	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Epirubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Gadofosveset trisodium—Rash—Cisplatin—testicular cancer	0.00064	0.00064	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Cisplatin—testicular cancer	0.000639	0.000639	CcSEcCtD
Gadofosveset trisodium—Erythema—Epirubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Epirubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Etoposide—testicular cancer	0.000636	0.000636	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Doxorubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Gadofosveset trisodium—Flushing—Doxorubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Doxorubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Gadofosveset trisodium—Flatulence—Epirubicin—testicular cancer	0.000629	0.000629	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Gadofosveset trisodium—Dizziness—Etoposide—testicular cancer	0.000615	0.000615	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Epirubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—testicular cancer	0.000613	0.000613	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Gadofosveset trisodium—Chills—Doxorubicin—testicular cancer	0.000609	0.000609	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Gadofosveset trisodium—Nausea—Cisplatin—testicular cancer	0.000603	0.000603	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Epirubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—testicular cancer	0.000596	0.000596	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Doxorubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Gadofosveset trisodium—Convulsion—Methotrexate—testicular cancer	0.000591	0.000591	CcSEcCtD
Gadofosveset trisodium—Vomiting—Etoposide—testicular cancer	0.000591	0.000591	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Doxorubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Gadofosveset trisodium—Erythema—Doxorubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Gadofosveset trisodium—Rash—Etoposide—testicular cancer	0.000586	0.000586	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Etoposide—testicular cancer	0.000586	0.000586	CcSEcCtD
Gadofosveset trisodium—Headache—Etoposide—testicular cancer	0.000583	0.000583	CcSEcCtD
Gadofosveset trisodium—Flatulence—Doxorubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—testicular cancer	0.000581	0.000581	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000577	0.000577	CcSEcCtD
Gadofosveset trisodium—Vertigo—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Gadofosveset trisodium—Syncope—Epirubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Doxorubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Gadofosveset trisodium—Palpitations—Epirubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Gadofosveset trisodium—Cough—Epirubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—testicular cancer	0.000557	0.000557	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Gadofosveset trisodium—Convulsion—Epirubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—testicular cancer	0.000553	0.000553	CcSEcCtD
Gadofosveset trisodium—Nausea—Etoposide—testicular cancer	0.000552	0.000552	CcSEcCtD
Gadofosveset trisodium—Hypertension—Epirubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—testicular cancer	0.000546	0.000546	CcSEcCtD
Gadofosveset trisodium—Chest pain—Epirubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Gadofosveset trisodium—Anxiety—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—testicular cancer	0.000541	0.000541	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00054	0.00054	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—testicular cancer	0.000538	0.000538	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Gadofosveset trisodium—Vertigo—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—testicular cancer	0.000531	0.000531	CcSEcCtD
Gadofosveset trisodium—Syncope—Doxorubicin—testicular cancer	0.00053	0.00053	CcSEcCtD
Gadofosveset trisodium—Confusional state—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Gadofosveset trisodium—Palpitations—Doxorubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Epirubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Gadofosveset trisodium—Oedema—Epirubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—testicular cancer	0.00052	0.00052	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Gadofosveset trisodium—Infection—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gadofosveset trisodium—Cough—Doxorubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Gadofosveset trisodium—Shock—Epirubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Gadofosveset trisodium—Convulsion—Doxorubicin—testicular cancer	0.000512	0.000512	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Epirubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Gadofosveset trisodium—Hypertension—Doxorubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Epirubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Epirubicin—testicular cancer	0.000506	0.000506	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Epirubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Gadofosveset trisodium—Chest pain—Doxorubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Gadofosveset trisodium—Anxiety—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—testicular cancer	0.0005	0.0005	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0005	0.0005	CcSEcCtD
Gadofosveset trisodium—Anorexia—Epirubicin—testicular cancer	0.000497	0.000497	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—testicular cancer	0.000497	0.000497	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—testicular cancer	0.00049	0.00049	CcSEcCtD
Gadofosveset trisodium—Hypotension—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Gadofosveset trisodium—Confusional state—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—testicular cancer	0.000484	0.000484	CcSEcCtD
Gadofosveset trisodium—Oedema—Doxorubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Doxorubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000481	0.000481	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—testicular cancer	0.00048	0.00048	CcSEcCtD
Gadofosveset trisodium—Infection—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Gadofosveset trisodium—Pain—Methotrexate—testicular cancer	0.000476	0.000476	CcSEcCtD
Gadofosveset trisodium—Shock—Doxorubicin—testicular cancer	0.000475	0.000475	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Doxorubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Doxorubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Doxorubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Epirubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Doxorubicin—testicular cancer	0.000466	0.000466	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Gadofosveset trisodium—Anorexia—Doxorubicin—testicular cancer	0.00046	0.00046	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Epirubicin—testicular cancer	0.000459	0.000459	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—testicular cancer	0.000455	0.000455	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Epirubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Gadofosveset trisodium—Hypotension—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Gadofosveset trisodium—Fatigue—Epirubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Gadofosveset trisodium—Constipation—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Gadofosveset trisodium—Pain—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—testicular cancer	0.000442	0.000442	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—testicular cancer	0.00044	0.00044	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Methotrexate—testicular cancer	0.00044	0.00044	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Doxorubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Doxorubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Epirubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Doxorubicin—testicular cancer	0.000425	0.000425	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Doxorubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Gadofosveset trisodium—Fatigue—Doxorubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Gadofosveset trisodium—Urticaria—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Gadofosveset trisodium—Constipation—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Gadofosveset trisodium—Pain—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Epirubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Epirubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—testicular cancer	0.00041	0.00041	CcSEcCtD
Gadofosveset trisodium—Asthenia—Methotrexate—testicular cancer	0.0004	0.0004	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Doxorubicin—testicular cancer	0.000397	0.000397	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000394	0.000394	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—testicular cancer	0.000394	0.000394	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Epirubicin—testicular cancer	0.000384	0.000384	CcSEcCtD
Gadofosveset trisodium—Urticaria—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Doxorubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Doxorubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—testicular cancer	0.000381	0.000381	CcSEcCtD
Gadofosveset trisodium—Asthenia—Epirubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Gadofosveset trisodium—Pruritus—Epirubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—testicular cancer	0.000368	0.000368	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Epirubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—testicular cancer	0.000354	0.000354	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Gadofosveset trisodium—Headache—Methotrexate—testicular cancer	0.000349	0.000349	CcSEcCtD
Gadofosveset trisodium—Asthenia—Doxorubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Gadofosveset trisodium—Dizziness—Epirubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Gadofosveset trisodium—Pruritus—Doxorubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Gadofosveset trisodium—Vomiting—Epirubicin—testicular cancer	0.000331	0.000331	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—testicular cancer	0.000331	0.000331	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Doxorubicin—testicular cancer	0.00033	0.00033	CcSEcCtD
Gadofosveset trisodium—Rash—Epirubicin—testicular cancer	0.000329	0.000329	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Epirubicin—testicular cancer	0.000328	0.000328	CcSEcCtD
Gadofosveset trisodium—Headache—Epirubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Gadofosveset trisodium—Dizziness—Doxorubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Gadofosveset trisodium—Nausea—Epirubicin—testicular cancer	0.00031	0.00031	CcSEcCtD
Gadofosveset trisodium—Vomiting—Doxorubicin—testicular cancer	0.000307	0.000307	CcSEcCtD
Gadofosveset trisodium—Rash—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Gadofosveset trisodium—Headache—Doxorubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Gadofosveset trisodium—Nausea—Doxorubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
